TG Therapeutics (TGTX) Reports Q3 Loss of $0.43
TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.43), versus ($0.48) reported last year.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.43), versus ($0.48) reported last year.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.